Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 5 | 0 | 46,40 € | 84,74 € | 82,64 % |
| Halozyme Therapeutics Inc. | 24 | 0 | 5 | 0 | 53,08 € | 55,17 € | 3,94 % |
| Verastem Inc. | 16 | 0 | 5 | 0 | 2,10 € | 16,20 € | 671,59 % |
| United Therapeutics | 25 | 1 | 5 | 1 | 295,10 € | 294,38 € | -0,24 % |
| Pacira Pharmaceuticals | 23 | 1 | 5 | 1 | 11,00 € | 41,35 € | 275,91 % |
| Insmed Inc. | 45 | 0 | 6 | 0 | 67,50 € | 76,80 € | 13,77 % |
| Eli Lilly Corp. | 66 | 0 | 7 | 0 | 843,60 € | 841,20 € | -0,28 % |
| Johnson & Johnson | 41 | 1 | 7 | 0 | 144,36 € | 196,23 € | 35,93 % |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | 14,08 € | 29,92 € | 112,47 % |
| AbbVie Inc. | 33 | 0 | 7 | 0 | 175,00 € | 180,36 € | 3,06 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 8 | 1 | 42,67 € | 56,72 € | 32,93 % |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 8 | 0 | 1.070,5 € | 1.082,5 € | 1,12 % |
| Neurocrine Bioscience | 42 | 0 | 10 | 0 | 134,95 € | 149,47 € | 10,76 % |
| Vertex Pharmaceuticals Inc. | 60 | 2 | 11 | 0 | 430,75 € | 440,93 € | 2,36 % |